Clinical trials recruiting for HR Positive HER2 Negative Advanced Breast Cancer
5
Recruiting trials
10
US states with sites
8
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Ribociclib | 2 |
| Abemaciclib | 1 |
| BBO-10203 | 1 |
| Bevacizumab | 1 |
| Chidamide | 1 |
| Dalpiciclib 125mg | 1 |
| Dalpiciclib 150mg | 1 |
| FOLFOX | 1 |
| Fulvestrant | 1 |
| Letrozole 2.5mg | 1 |
| Palbociclib | 1 |
| TYK-00540 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Indiana | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| New York | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Washington | 1 |
| Wisconsin | 1 |
Top cities
Boston, Massachusetts 1Dallas, Texas 1Duarte, California 1Houston, Texas 1Indianapolis, Indiana 1Kansas City, Missouri 1Los Angeles, California 1Madison, Wisconsin 1Nashville, Tennessee 1New York, New York 1
Self-screener
Recruiting trials
- A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
- Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
- Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors
Related conditions
Trials recruiting for HR Positive HER2 Negative Advanced Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Solid Tumor, Adult 38Metastatic Lung Cancer 12Metastatic Colorectal Cancer 60Metastatic breast cancer 131Lung cancer 2180HR+/HER2- Breast Cancer 17Hormone Receptor Positive HER-2 Negative Breast Cancer 8Hormone Receptor Positive Breast Carcinoma 13Hormone Receptor Positive Breast Cancer 24
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HR Positive HER2 Negative Advanced Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.